As two new disease-modifying Alzheimer’s treatments move through the Health Canada approval process, early diagnosis and access are more critical than ever. “In Ontario, people often wait years for a formal dementia diagnosis,” says Adam Morrison, Senior Director of Public Policy & Partnerships. Prioritizing access to these innovative treatments could save lives, reduce the burden on care partners, and save our province millions of dollars.
Learn more and find out how you can help advocate for change: https://bit.ly/4dDcFBI
